Idera Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.86 |
Market Cap |
$73.14 M |
Shares Outstanding |
28.02 M |
Public Float |
22.28 M |
Address |
505 Eagleview Boulevard Exton Pennsylvania 19341 United States |
Employees | - |
Website | http://www.iderapharma.com |
Updated | 07/08/2019 |
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which focuses on the discovery, development and commercialization of novel oligonucleotide therapeutics for oncology and rare diseases. The firm uses two distinct proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor targeting technology and third-generation antisense technology. The company was founded by Paul C. |